More PRNewswire
View Older Stories View Newer Stories-
Corteva to Participate in the 2024 BMO Farm to Market Chemicals Conference
-
MMTEC, INC. ANNOUNCES A PAUSE ON FINANCING ACTIVITIES IN THE NEXT SIX MONTHS
-
Yuengling Releases Limited-Edition Team RWB Stars & Stripes Lager Cans to Honor Veterans
-
eVisit and Monstarlab Forge Strategic Alliance to Revolutionize Virtual Care Platforms
-
IM Cannabis Reports First Quarter Financial Results
-
inride CONSUMER TO DEALER AUTO AUCTION PLATFORM NOW LIVE
-
soona adds co-founder of Klaviyo and co-founder of Havenly as independent board members
-
JD Saint-Martin joins Workleap's Board of Directors
-
A Connected and Sustainable Energy World - 17th Singapore International Energy Week
-
SIGMA LITHIUM INCREASES PROVEN & PROBABLE OPEN PIT MINERAL RESERVE BY 40% TO 77Mt EXTENDING OPERATIONS TO 25 YEARS
-
NeuroTherapia Receives Grant from Alzheimer's Association for Development of First-in-Class Drug for Alzheimer's Disease
-
Mastech Digital Reports Sequential Revenue Growth for the First Time since the Third Quarter of 2022
-
DeFi Technologies Provides Monthly Corporate Update: Subsidiary Valour Reports Assets Under Management at C$748 Million, Up 47.2% This Fiscal Year, Bolstered by Strong Net Inflows of C$6.6 Million, Am
-
Exiger and Hill Holliday Celebrate Supply Chain and Risk Professionals Who "Save the Day"
-
EchoStar Announces Financial Results for the Three Months Ended March 31, 2024
-
U.S. Gold Corp. Announces Mine Operating Permit Approval for the CK Gold Project in Wyoming
-
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
-
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
-
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending Vast Majority of Its Debt Maturities into 2028 and 2029
-
Wipro and Kognitos Collaborate to Deploy GenAI-Based Business Automation Solutions
-
SCOTTIE RESOURCES OUTLINES 2024 EXPLORATION PLAN
-
The Next Big Thing in AI is Moby Dick
-
LeddarTech to Host Investor and Business Update Call on May 15, 2024
-
WhiteHorse Finance, Inc. Announces First Quarter 2024 Earnings Results and Declares Quarterly Distribution of $0.385 Per Share
-
Naborforce Expands to Greensboro, Winston-Salem, High Point, and Wilmington to Support Older Adults and their Families as North Carolina's Aging Population Doubles
-
CB&I Awarded Contract by TotalEnergies and OQ for Full Containment Liquefied Natural Gas Tank in Oman
-
Global Times: China and France open a new chapter in joint exploration of nuclear energy after 40 years of partnership and trust
-
Natural Grocers® Hosts Fourth Annual Body Care & Beauty Bonanza, May 9-31, 2024
-
Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market
-
Mallard Manufacturing Joins the MacLean-Fogg Family of Companies
-
7-Eleven, Inc. to Release New Limited Edition Gatorade Thirst Quencher Flavor: Midnight Ice
-
GOBankingRates Announces Its Inaugural List of Money's Most Influential Women
-
Espoo-based Kuori Oy founders win 2024 Entrepreneur of the Year award
-
Charlotte's Web Reports 2024 First Quarter Financial Results
-
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Tripadvisor, Inc. Earnings Press Release Available on Company's Investor Relations Site
-
Window Hero expands its reach in the South with first location in Mississippi
-
ENTRÉE RESOURCES ANNOUNCES FIRST QUARTER 2024 RESULTS
-
Valvoline Inc. Reports Second Quarter Results
-
Canadian Solar Secures 193 MW of BESS Projects in Japan's Inaugural Long-term Decarbonization Power Source Auction
-
TETROUS ANNOUNCES FIRST SURGICAL PROCEDURES USING ENFIX TAC™ DEMINERALIZED BONE FIBER IMPLANTS TO ENHANCE ENTHESIS HEALING IN ROTATOR CUFF REPAIR
-
EREZ ASSET MANAGEMENT SENDS LETTER TO WHITESTONE SHAREHOLDERS QUESTIONING RECENT CONDUCT OF WHITESTONE REIT BOARD
-
WELL Health Reports Record Quarterly Revenue and Record Net Income for a first quarter in Q1-2024 and Increases Both Revenue and Adjusted EBITDA Guidance for 2024
-
Acepodia Announces Preliminary Clinical Data From Phase 1 Clinical Trial of ACE1831, First-Ever Anti-CD20 Antibody Conjugated Allogenic Gamma Delta T Cell Therapy for Non-Hodgkins Lymphoma
-
Opera to Participate in Upcoming Investor Conferences
-
Oncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
-
Sunoco LP Announces First Quarter 2024 Financial and Operating Results
-
Gemoo Launched CapUp to Make Viral Videos for Tiktok, Instagram, and YouTube easily and Instantly
-
VIZSLA SILVER REPORTS ADDITIONAL HIGH-GRADE INTERCEPTS AND REFINED INTERPRETATIONS AT LA LUISA
-
Pixelgen Technologies Announces Peer-Review Publication on Molecular Pixelation Technology in Nature Methods
